Clinical Trial Update: Phase 2 Study of ADX-038 in Participants With Geographic Atrophy [Phase 2]

View source ↗

Summary

Phase 2 trial of ADX-038 for geographic atrophy secondary to age-related macular degeneration is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration
• Geographic Atrophy

Drugs mentioned

• ADX-038

Snippet

Sponsor: ADARx Pharmaceuticals, Inc. | Conditions: Geographic Atrophy Secondary to Age-related Macular Degeneration | Phase 2 | Status: RECRUITING